Developing Panels of Laboratory Models of Childhood Cancer
Cell lines + patient-derived xenografts (PDXs) enable biological and preclinical therapeutic studies informing clinical trials. Developing, characterizing and insuring distribution of such models for childhood cancers should be funded by NCI.
Voting
0
votes
Ideate
Idea No. 126